Integrative Biology & Medicine
Dmytro Zubov and Roman Vasyliev, a team representing ilaya Medical company, presented at the #integrativebio conference today. The subject was "Ukrainian biomedical tissue-engineered product for treatment of critical-sized bone defects and AVN: manufacturing and first-in-human clinical outcomes." The Ilaya clinic, which has treated more then 20,000 patients, developed the technology based on its experience in orthopedic medical cellular technologies. Together with traumatologist and orthopedist Volodymyr Oksimets, Vasyliev and Zubov are the authors of a patent for a new method of treating Avascular Necrosis (AVN). ilaya is speaking FDA to make the treatment approval in the United States. The team's report was extremely well received at the conference.